FIREFLY NEUROSCIENCE, INC. (AIFF): Nasdaq/NYSE listing notice — WaveDancer receives second Nasdaq delisting notice for failing to submit stockholders' equity compliance plan

FIREFLY NEUROSCIENCE, INC.

Stockholders' equity was $2,371,318 as of March 31, 2023, below the $2,500,000 minimum.
Company did not submit a compliance plan by Nasdaq's July 10 deadline.
On July 11, Nasdaq notified that this non-compliance is an additional delisting basis.
Company already faces delisting for minimum bid price; plans to appeal and use reverse split.
Nasdaq Panel will consider both stockholders' equity and bid price matters.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

FIREFLY NEUROSCIENCE, INC. received a nasdaq deficiency notice notice regarding stockholders equity.

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity

Exact text from the filing

June 2, 2023 WaveDancer, Inc. (the “Company”) was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that it was out of compliance with Nasdaq’s continued listing requirements because as of March 31, 2023, our reported stockholders’ equity of $2,371,318 was below the minimum requirement of $2,500,000. Under Nasdaq rules, the Company had 45 days, or until July 10, 2023, to submit a plan to regain compliance. In our June 8, 2023 Form 8-K, the Company disclosed its intention to timely request a hearing before the Nasdaq Hearings Panel (the “Panel”) to present its plan for regaining compliance wit

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

FIREFLY NEUROSCIENCE, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-020020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.